Diagnostic gastroenterology

Motus GI to Release Second Quarter Results and Provide a Business Update on August 12

Retrieved on: 
Thursday, July 29, 2021
Motus, Diagnostic gastroenterology, Endoscopy

FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its second quarter financial results on Thursday, August 12, 2021, after the market close.

Key Points: 
  • FORT LAUDERDALE, Fla., July 29, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that the Company will release its second quarter financial results on Thursday, August 12, 2021, after the market close.
  • Management will host a conference call and webcast at 4:30 p.m.
  • ET to discuss the results and provide updates on recent corporate developments.
  • ET

DGAP-News: Vitruvia Medical AG: Successful certification for the reprocessing of 'critical C' devices - Vitruvia Medical now also providing circular systems for highest risk-level medical devices

Retrieved on: 
Wednesday, July 28, 2021
Medicine, Clinical medicine, Computer-assisted surgery, Medical technology, Telemedicine, Diagnostic gastroenterology, Endoscopy, ISO 13485, Robot-assisted surgery, Robot, Surgery

Schnebeck, July 28, 2021 Vitruvia Medical, which specializes in circular systems for highly complex medical products, particularly robot-assisted surgery, now also holds

Key Points: 
  • Schnebeck, July 28, 2021 Vitruvia Medical, which specializes in circular systems for highly complex medical products, particularly robot-assisted surgery, now also holds
    DIN EN ISO 13485:2016 (KRINKO) certification.
  • This means that Vitruvia Medical is now certified to reprocess all surgical instruments, including those classed at the highest "critical C" risk level.
  • These include flexible endoscopes as well as all instruments and optics for robot-assisted surgery which are authorized for reprocessing by the manufacturer.
  • With this sustainable concept, hospitals save both investment and operating costs when using robot-assisted surgical systems and also avoid the potential underuse of their own circular systems.

United States Endoscopy Device Market Analysis & Forecasts 2021-2025 with COVID-19 Impact Analysis - ResearchAndMarkets.com

Retrieved on: 
Monday, July 26, 2021
Medical devices, Health, Diagnostic gastroenterology, Endoscopy

The "The US Endoscopy Device Market: Size & Forecast with Impact Analysis of COVID-19, 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The US Endoscopy Device Market: Size & Forecast with Impact Analysis of COVID-19, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • This report provides an in depth analysis of the US endoscopy device Market by value, by product, by endoscopes, by region, etc.
  • The report provides a regional analysis of the global endoscopy device market, including the following regions: North America, Europe, Asia Pacific and Middle East and Africa.
  • The report also provides a detailed analysis of the COVID-19 impact on the endoscopy device market.

Global Endoscope Reprocessing Market (2021 to 2026) - Growing Medical Devices Industry in Emerging Economies Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021
Health, Medical Supplies, Medical devices, Articles, Economy, Diagnostic gastroenterology, Endoscopy, Emerging market, Disinfectant, Academic disciplines

The global endoscope reprocessing market is projected to USD 3.2 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 9.0% from 2021 to 2026.

Key Points: 
  • The global endoscope reprocessing market is projected to USD 3.2 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 9.0% from 2021 to 2026.
  • Also, the growing medical devices industry in emerging economies is anticipated to offer an opportunity for the growth of the market during the forecast period.
  • High-level disinfectants and test strips are expected to hold the largest share of the endoscope reprocessing market, by product in 2021.
  • In 2020, the high-level disinfectants and test strips segment accounted for the largest share of the global endoscope reprocessing market.

Olympus to Support Endoscopic AI Diagnosis Education for Doctors in Thailand

Retrieved on: 
Wednesday, July 21, 2021
Technology, Software, Biotechnology, Training, Hardware, Health, General Health, Education, Oncology, Clinical medicine, Medicine, Endoscopy, Diagnostic gastroenterology, Narrow-band imaging

Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) took part in a ground-breaking project as a business promoter, in cooperation with the Ministry of Internal Affairs and Communications (MIC) of Japan, entitled, "Survey Study for International Expansion of Endoscopes Utilizing High-definition Imaging Technology AI Diagnosis Support System in Thailand." The project aims to develop advanced endoscopy diagnostics in Thailand, where there are relatively few endoscopists.

Key Points: 
  • Clinical use by Indian doctors and discussion with Japanese physicians showed the effectiveness and potential for future dissemination of the ultra-expanded endoscope Endocyto1 and the endoscope diagnostic imaging support software with AI EndoBRAIN2 and EndoBRAIN-EYE3.
  • For the project in Thailand, in collaboration with CYBERNET SYSTEMS CO., LTD., Olympus conduct a demonstration survey on the effectiveness and potential dissemination of the AI diagnostic support system in collaboration with Thai Gastrointestinal Endoscopy Association (TAGE).
  • Olympus participated in this project to support trained specialists to train doctors in Thailand and neighboring countries and to contribute to the dissemination and development of endoscopic diagnostics using the latest AI technology.
  • This project aims to contribute to the introduction and dissemination of Japans endoscopic AI diagnostic support system to Thailand and neighboring countries in response to the social issue of increasing cancer prevalence in Thailand.

Palliare announces US FDA 510(k) clearance to extend the indications of its EVA15 insufflation technology for use in endoscopic surgery

Retrieved on: 
Thursday, July 15, 2021
Health, Medical devices, Technology, Hospitals, Surgery, Hardware, Biotechnology, Medicine, Clinical medicine, Endoscopy, Medical terminology, Digestive system surgery, Laparoscopy, Diagnostic gastroenterology, Insufflation, Therapeutic endoscopy, AME Publishing Company, the EVA15 Insufflator, Palliare, THE EVA15 INSUFFLATOR, PALLIARE

Palliare, an emerging company with the vision to create a safer operating room, today announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends the capabilities of its EVA15 continuous pressure insufflation technology from laparoscopic surgery to endoscopic and endoluminal surgery.

Key Points: 
  • Palliare, an emerging company with the vision to create a safer operating room, today announced that it has received FDA 510(k) clearance for its END-200 tubeset, which extends the capabilities of its EVA15 continuous pressure insufflation technology from laparoscopic surgery to endoscopic and endoluminal surgery.
  • EVA15 is the first insufflator of its kind to be brought to market which will allow intelligent leak-tolerant constant pressure insufflation during endoscopic surgery, features that EVA15 currently offers for laparoscopic and robotic surgery.
  • For complex, long or high leak therapeutic endoscopy procedures, current insufflation requires careful ongoing management by the endoscopist.
  • Palliare was founded in 2018 as a spinout from Irish gastro-diagnostic company Crospon, which was acquired by Medtronic (NYSE:MDT) in 2017.

Provation and the Australian Commission on Safety and Quality in Health Care strive to improve colonoscopy documentation with new requirements and technology

Retrieved on: 
Tuesday, July 13, 2021
Health, Medicine, Clinical medicine, Cancer screening, Colonoscopy, Diagnostic gastroenterology, Endoscopy, Large intestine, Health care quality, Patient safety organization

In January 2019, funded by the Australian Government Department of Health, the Commission developed the Colonoscopy Clinical Care Standard.

Key Points: 
  • In January 2019, funded by the Australian Government Department of Health, the Commission developed the Colonoscopy Clinical Care Standard.
  • The Standard includes nine quality statements and a set of four clinical indicators for proper colonoscopy procedure care.
  • By reporting on the Commissions indicators, Australian facilities can increase documentation standardisation for colonoscopies and improve quality patient care.
  • The Australian Commission on Safety and Quality in Health Care is an Australian Government agency that leads and coordinates national improvements in the safety and quality of health care based on the best available evidence.

Provation and the Australian Commission on Safety and Quality in Health Care strive to improve colonoscopy documentation with new requirements and technology

Retrieved on: 
Tuesday, July 13, 2021
Health, Medicine, Clinical medicine, Cancer screening, Colonoscopy, Diagnostic gastroenterology, Endoscopy, Large intestine, Health care quality, Patient safety organization

In January 2019, funded by the Australian Government Department of Health, the Commission developed the Colonoscopy Clinical Care Standard.

Key Points: 
  • In January 2019, funded by the Australian Government Department of Health, the Commission developed the Colonoscopy Clinical Care Standard.
  • The Standard includes nine quality statements and a set of four clinical indicators for proper colonoscopy procedure care.
  • By reporting on the Commissions indicators, Australian facilities can increase documentation standardisation for colonoscopies and improve quality patient care.
  • The Australian Commission on Safety and Quality in Health Care is an Australian Government agency that leads and coordinates national improvements in the safety and quality of health care based on the best available evidence.

FDA Grants 510(k) Clearance for Fujifilm’s New Endosurgical Image Enhancement Technology for the Company’s ELUXEO Surgical System

Retrieved on: 
Thursday, July 8, 2021
Clinical medicine, Medicine, Medical specialties, Endoscopy, Diagnostic gastroenterology, Digestive system surgery, Laparoscopy, Society of American Gastrointestinal and Endoscopic Surgeons, Hemoglobin

The new image enhancement technology enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue using laparoscopic and/or endoscopic imaging.

Key Points: 
  • The new image enhancement technology enables real-time visualization of hemoglobin oxygen saturation (StO2) levels in tissue using laparoscopic and/or endoscopic imaging.
  • This new technology is an upgrade to Fujifilms ELUXEO Surgical System .
  • Each image enhancement technology provides physicians with unique data allowing them to better diagnose issues while in procedures.
  • Fujifilm will showcase its ELUXEO Surgical System with this new image enhancement technology at the annual Society of American Gastrointestinal and Endoscopic Surgeons ( SAGES ) conference August 31 - September 3, 2021.

SonoScape obtains CE Mark for its linear array echoendoscope EG-UC5T

Retrieved on: 
Friday, July 2, 2021
Medicine, Clinical medicine, Diagnostic gastroenterology, Acoustics, Medical equipment, Medical imaging, Medical ultrasound, Physical therapy, Endoscopy, Health care

SHENZHEN, China, July 2, 2021 /PRNewswire/ -- On April 30th, SonoScape received the CE-marking, the product's "Passport to Europe", for its linear-array echoendoscope EG-UC5T.

Key Points: 
  • SHENZHEN, China, July 2, 2021 /PRNewswire/ -- On April 30th, SonoScape received the CE-marking, the product's "Passport to Europe", for its linear-array echoendoscope EG-UC5T.
  • EG-UC5T is characterised by its large, 4.0-mm instrument channel and its short rigid distal end, pushing the boundaries of therapeutic excellence.
  • With the arrival of the linear-array echoendoscope EG-UC5T, SonoScape users are not only able to perform the adequate tissue sampling, but also various therapeutic interventional endoscopic procedures under the sonographic guidance.
  • Focused on delivering high quality products, SonoScape continues to bring significant value to the world of endoscopy.